208 related articles for article (PubMed ID: 33838175)
1. Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD).
Hamilton MC; Heintz MM; Pfohl M; Marques E; Ford L; Slitt AL; Baldwin WS
Food Chem Toxicol; 2021 Jun; 152():112175. PubMed ID: 33838175
[TBL] [Abstract][Full Text] [Related]
2. Human CYP2B6 produces oxylipins from polyunsaturated fatty acids and reduces diet-induced obesity.
Heintz MM; Eccles JA; Olack EM; Maner-Smith KM; Ortlund EA; Baldwin WS
PLoS One; 2022; 17(12):e0277053. PubMed ID: 36520866
[TBL] [Abstract][Full Text] [Related]
3. Increased Perfluorooctanesulfonate (PFOS) Toxicity and Accumulation Is Associated with Perturbed Prostaglandin Metabolism and Increased Organic Anion Transport Protein (OATP) Expression.
Williams LA; Hamilton MC; Edin ML; Lih FB; Eccles-Miller JA; Tharayil N; Leonard E; Baldwin WS
Toxics; 2024 Jan; 12(2):. PubMed ID: 38393201
[TBL] [Abstract][Full Text] [Related]
4. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice.
Marques E; Pfohl M; Auclair A; Jamwal R; Barlock BJ; Sammoura FM; Goedken M; Akhlaghi F; Slitt AL
Toxicol Appl Pharmacol; 2020 Dec; 408():115250. PubMed ID: 32979393
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice.
Huck I; Beggs K; Apte U
Int J Toxicol; 2018; 37(5):383-392. PubMed ID: 30134762
[TBL] [Abstract][Full Text] [Related]
6. Perfluorooctane Sulfonate-Induced Hepatic Steatosis in Male Sprague Dawley Rats Is Not Attenuated by Dietary Choline Supplementation.
Bagley BD; Chang SC; Ehresman DJ; Eveland A; Zitzow JD; Parker GA; Peters JM; Wallace KB; Butenhoff JL
Toxicol Sci; 2017 Dec; 160(2):284-298. PubMed ID: 28973659
[TBL] [Abstract][Full Text] [Related]
7. Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.
Heintz MM; Kumar R; Rutledge MM; Baldwin WS
J Nutr Biochem; 2019 Aug; 70():125-137. PubMed ID: 31202118
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
Heintz MM; McRee R; Kumar R; Baldwin WS
PLoS One; 2020; 15(3):e0229896. PubMed ID: 32155178
[TBL] [Abstract][Full Text] [Related]
9. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.
Liu Z; Li L; Wu H; Hu J; Ma J; Zhang QY; Ding X
Drug Metab Dispos; 2015 Feb; 43(2):208-16. PubMed ID: 25409894
[TBL] [Abstract][Full Text] [Related]
11. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
12. Perinatal exposure to perfluorooctane sulfonate affects glucose metabolism in adult offspring.
Wan HT; Zhao YG; Leung PY; Wong CK
PLoS One; 2014; 9(1):e87137. PubMed ID: 24498028
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
14. High fat diet induced obesity is mitigated in Cyp3a-null female mice.
Kumar R; Litoff EJ; Boswell WT; Baldwin WS
Chem Biol Interact; 2018 Jun; 289():129-140. PubMed ID: 29738703
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
16. The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.
Marques ES; Agudelo J; Kaye EM; Modaresi SMS; Pfohl M; Bečanová J; Wei W; Polunas M; Goedken M; Slitt AL
Toxicology; 2021 Oct; 462():152921. PubMed ID: 34464680
[TBL] [Abstract][Full Text] [Related]
17. PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport.
Wan HT; Zhao YG; Wei X; Hui KY; Giesy JP; Wong CK
Biochim Biophys Acta; 2012 Jul; 1820(7):1092-101. PubMed ID: 22484034
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
[TBL] [Abstract][Full Text] [Related]
19. Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice.
Bijland S; Rensen PC; Pieterman EJ; Maas AC; van der Hoorn JW; van Erk MJ; Havekes LM; Willems van Dijk K; Chang SC; Ehresman DJ; Butenhoff JL; Princen HM
Toxicol Sci; 2011 Sep; 123(1):290-303. PubMed ID: 21705711
[TBL] [Abstract][Full Text] [Related]
20. A CYP2B6-humanized mouse model and its potential applications.
Li L; Zhang QY; Ding X
Drug Metab Pharmacokinet; 2018 Feb; 33(1):2-8. PubMed ID: 29402634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
